PHS
EVH icon

PFM Health Sciences’s Evolent Health EVH Stock Holding History

PFM Health Sciences’s Portfolio EVH Stock Details EVH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q4 		– Sell
-2,063,033
Closed -$36.7M – 84
2017
Q3 		$36.7M Buy
2,063,033
+1,614,855
+360% +$33.3M 0.72% 48
2017
Q2 		$11.4M Sell
448,178
-32,244
-7% -$775K 0.31% 73
2017
Q1 		$10.7M Buy
+480,422
New +$9.22M 0.27% 84

Other funds holding EVH

Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return
William Blair & Company
William Blair & Company Chicago, Illinois $38.4B AUM 25.71% 1-Year Est. Return
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return
RP
Riverbridge Partners Minneapolis, Minnesota $3.58B AUM 4.02% 1-Year Est. Return
CWAM
Columbia Wanger Asset Management Chicago, Illinois $6.69B AUM 31.14% 1-Year Est. Return
FG
Formula Growth Montreal, Quebec, Canada $284M AUM 54.56% 1-Year Est. Return

PFM Health Sciences's EVH Position: Q4 2017 in Review

PFM Health Sciences sold out of Evolent Health (EVH) in Q4 2017, closing a stake of 2,063,033 shares — an estimated $36.7M sold.

PFM Health Sciences first reported a position in EVH in Q1 2017 and held it in 3 quarters. The position peaked at $36.7M in Q3 2017. 156 funds tracked by Wall St. Rank hold EVH as of Q4 2017.

  • PFM Health Sciences reported no remaining Evolent Health position as of Q4 2017 after selling out during the quarter.
  • PFM Health Sciences sold 2,063,033 Evolent Health shares in Q4 2017, an estimated $36.7M.
  • PFM Health Sciences first reported a position in Evolent Health in Q1 2017 and held it in 3 quarters.
  • PFM Health Sciences's Evolent Health position peaked at $36.7M in Q3 2017.
  • 156 funds tracked by Wall St. Rank held Evolent Health as of Q4 2017.

Based on PFM Health Sciences's 13F filing for Q4 2017, filed 14 Feb 2018.